The glycopeptide standard is comprised of an A2G2S2 glycan attached to the asparagine amino acid of a peptide with the sequence Lysine-Valine-Alanine-Asparagine-Lysine-Threonine (KVANKT), 10µg.m/z: 2865.1763

The Fetuin Glycoprotein Standard is a highly sialylated glycoprotein standard which can be used as a positive control during glycan release and labelling (particularly for DMB sialic acid analysis). Fetuin exists in a variety of glycoforms containing bi-, tri-, and tetraantennary N-linked oligosaccharides with variable sialylation, as well as O-linked glycans.

The Fetuin Glycoprotein Standard was developed for use as a positive control during glycan release and labelling (particularly for DMB sialic acid analysis). Fetuin exists in a variety of glycoforms containing bi-, tri-, and tetraantennary N-linked oligosaccharides with variable sialylation, as well as O-linked glycans.

The Fetuin Glycoprotein Standard was developed for use as a positive control during glycan release and labelling (particularly for DMB sialic acid analysis). Fetuin exists in a variety of glycoforms containing bi-, tri-, and tetraantennary N-linked oligosaccharides with variable sialylation, as well as O-linked glycans.

The IgG glycoprotein standard for use during glycan release and labelling. This product is purified from human blood. Human IgG glycoprotein standard contains a mixture of gamma-type antibodies.

The IgG glycoprotein standard for use during glycan release and labelling.

The mixture is composed of two glycopeptides which are comprised of either an F(6)A2 glycan or an F(3)A2 glycan attached to the asparagine amino acid of a peptide with the sequence Lysine-Valine-Alanine-Asparagine-Lysine-Threonine (KVANKT).